Safety and Efficacy of Orally Administered NUV001 Nutraceutical Supplement in Sickle Cell Disease Patients

Clinical trial NCT05791591 · COMPLETED

Trial details

NCT number: NCT05791591
Sponsor: LGD
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2023-04-16
Primary completion: 2024-07-03
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.